Shanghai Shuyao Intelligence Clinches Dual Honors in the 2023 Future Healthcare 100 List

 On May 5, the 7th Future Healthcare 100 Conference, themed “Beyond East and West,” officially kicked off at the Zhangjiang Science Hall in Shanghai, with the official release taking place at the Top 100 Awards Gala on the evening of May 6.“2023 Future Healthcare Top 100 Series Rankings,” Shanghai Shuyao Intelligent Technology Co., Ltd.Won for its strong scientific and technological research capabilities in the field of digital therapeutics and the promising development prospects of its innovative medical value“Top 100 Innovative Digital Health Companies in China” and “Value Sector Award”Dual Honors.

Launched in 2015, the Future Healthcare Top 100 list is China’s first ranking focused on innovative healthcare companies that are not publicly listed. It was introduced by VB100, VCBeat, and Eggshell Research Institute. The list aims to identify Chinese innovators who truly represent the future of healthcare, uncover the core forces driving China’s future healthcare industry, and promote innovation and transformation within the health and medical sector.

Conference Venue

China’s Top 100 Digital Healthcare Companies focuses on enterprises that leverage innovative digital technologies—such as the internet, artificial intelligence, the Internet of Things (IoT), and 5G—to empower the digital transformation of medical processes, the development of hospital information systems, and the digital upgrading of medical equipment. The selection criteria reference each company’s most recent valuation and growth potential, with particular emphasis on innovation and breakthroughs in technology and products. SDODT stood out from among thousands of companies due to its outstanding performance across multiple dimensions, including innovative breakthroughs, value growth, and industry contributions.Selected for the main list of “Top 100 Future Healthcare Companies – China’s Top 100 Innovative Digital Health List” and featured on the “Value Sector List” for its commercial applications in the field of digital therapeutics.

Award Trophy

As Li Wenyu, CEO of SDODT, stated in2023 7th Future Healthcare Top 100 Conference: Brain Science Industry Trends Development ForumAs mentioned above, SDODT has always been committed toUshering in the Era of Digital Therapeutics for Brain HealthDriven by its mission, SDODT has spent the past two years exploring the integration of non-invasive brain-computer interfaces with digital therapeutics, focusing on the diagnosis and treatment of neurological disorders, and continuously reinforcing its position as an industry-leading high-tech enterprise in digital therapeutics. Currently, SDODT has entered a period of rapid growth through innovative medical integration with digital therapeutics.Integrating Multi-Pipeline Reserves and Hardware Development to Gradually Build a Digital Therapeutics Platform for Neurological DisordersThis award serves as a testament to the market’s strong recognition and support for SDODT’s robust R&D capabilities and innovative business model, while also motivating SDODT to continue advancing forward.

Li Wenyu, CEO of SDODT (second from right)

SDODT’s Current Pipeline of Mature, In-House Developed ProductsADHD"Attention Enhancement Training Software" is a serious functional game for therapeutic intervention, based on the clinical gold standard treatment methods, providing pediatric patients with electronic game products that have therapeutic functions. It has been launched this year.Obtained China’s first Class II medical device certificate for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), becoming the first approved “digital prescription drug” in this field. “Shumian Brain-Computer Monitoring System》For diagnostic management, through the combination of brain-computer interface and mobile APP, byRich Accumulation of Sleep EEG Data and AI Models Forms a Technical Barrier, providing users with digital, objective, and accurate diagnoses, continuously collecting health data, and becomingPersonal Health Management Assistant. "Autism Rehabilitation Training Software"To prevent diseases, AR/VR-integrated early screening products provide digital solutions for individuals who have not been diagnosed but are at risk of certain diseases.Early screening and intervention methods. Through Brain-Computer Interface (BCI) + VR + adaptive algorithms, developing a more efficient and precise intelligent therapy system to serve children aged 5–12 with autism spectrum disorder, helping them better integrate into society.

On-Site at the Forum on Trends in the Brain Science Industry

In the future, SDODT will remain true to its original aspiration and mission, continuously strengthen its R&D and innovation capabilities in the treatment of neurological disorders, and truly empower the development of innovative healthcare.Continuously exploring and understanding the human brain to help people improve their mental health, promote the development of digital therapeutics in China, and assist more patients with brain disorders.。2023 marked the inaugural year of commercialization for SDODT’s intelligent products. Advancing product commercialization will better facilitate the iteration and optimization of the product pipeline, strengthen related channel development, and simultaneously accelerateProduct R&D and software/hardware upgrades for psychiatric disorders such as Parkinson’s disease, Alzheimer’s disease, depression, and sleep disorders, accelerate the R&D of an open brain-computer interface (BCI) platform, provide software platform support for a wider range of BCI products, promote and accelerate the commercial application and practical implementation of BCI products, and strive continuously to gradually build comprehensive and systematic solutions in the field of neuropsychiatric disorders.Drive the development and transformation of the medical and healthcare industry, supporting China’s “2030 Brain Health Initiative.”

SDODT, established in 2021, is an innovative digital therapeutics company centered on independent R&D and a member of the Century Huatong ecosystem. By integrating biosensing applications with artificial intelligence analysis and leveraging cutting-edge research in neural networks, SDODT is committed to providing digital therapeutic solutions for the diagnosis and treatment of neurological disorders, thereby advancing the development of digital precision medicine. Meanwhile, the company continuously explores effective applications of digital health across various fields to promote frontier research in neuroscience.

The company has always upheld a spirit of proactive innovation and determined progress, centering on clinical needs and leveraging EEG bioinformation technology and core algorithmic analysis to develop technologies, products, and platforms for digital therapeutics, thereby pioneering efficient, convenient, and universally applicable digital therapeutic solutions. Meanwhile, SDODT is actively expanding into brain-computer interface (BCI)-related fields. By capitalizing on its advantages in brain science and its open software service platform for BCI, the company fosters collaboration and translation of research outcomes between BCI research and applications, establishing a robust platform to facilitate integrated innovation and foundational cooperation across the industry chain.

SDODT has assembled a team of outstanding, multidisciplinary experts and has completed the development of a portfolio of digital therapeutics products, including the “Attention Enhancement Training Software” for Attention-Deficit/Hyperactivity Disorder (ADHD), the “Autism Rehabilitation Training Software” for Autism Spectrum Disorder (ASD), and the brain-computer interface product “ShuMian.” This achievement lays a solid foundation for the broader application of digital medical technologies.

In the future, SDODT will continuously strengthen its scientific research and technological development. By leveraging continuous innovation in technology and products, it will explore and deepen the understanding of the human brain, help people improve their mental health, serve society, and provide health safeguards for a better life for humanity.